9TB1 image
Deposition Date 2025-11-19
Release Date 2026-03-25
Last Version Date 2026-04-15
Entry Detail
PDB ID:
9TB1
Keywords:
Title:
Crystal structure of an acylated GLP-1/GIP analogue peptide
Biological Source:
Source Organism(s):
Method Details:
Experimental Method:
Resolution:
1.59 Å
R-Value Free:
0.24
R-Value Work:
0.20
Space Group:
P 43
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:GG-353
Chain IDs:A (auth: B)
Chain Length:39
Number of Molecules:1
Biological Source:Heloderma suspectum cinctum
Ligand Molecules
Primary Citation
Crystallization and 1.6 angstrom resolution crystal structure of an acylated GLP-1/GIP analogue peptide.
Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 82 114 124 (2026)
PMID: 41841205 DOI: 10.1107/S2053230X26001937

Abstact

With the meteoric rise in interest in GLP-1 and GIP analogue peptides in recent years, there is a drive for the use of alternative purification techniques to alleviate processing bottlenecks and reduce the cost of peptide manufacturing. However, a lack of reported crystal structures for this class of peptides has hindered molecular-scale understanding of GLP-1/GIP analogue peptide crystallization, particularly related to acylated peptides. This paper therefore reports what is believed to be the first crystal structure of a GLP-1 and GIP analogue lipopeptide. Crystals obtained using a microseed matrix-screening protocol diffracted to </=1.6 A resolution in space group P4(3), with unit-cell parameters a = b = 64.66, c = 11.42 A. Model building and the resultant structural analysis reveals that the predominantly helical peptide forms a uniquely porous spiral crystal structure composed of clockwise-ascending monomers in a square pattern, with aromatic C...H-pi interactions around Phe22 forming the primary crystal contact between neighbouring square motifs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback